ID   CDK8_HUMAN              Reviewed;         464 AA.
AC   P49336; Q5VUF3; Q6ISB5;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   15-MAR-2017, entry version 162.
DE   RecName: Full=Cyclin-dependent kinase 8;
DE            EC=2.7.11.22;
DE            EC=2.7.11.23;
DE   AltName: Full=Cell division protein kinase 8;
DE   AltName: Full=Mediator complex subunit CDK8;
DE   AltName: Full=Mediator of RNA polymerase II transcription subunit CDK8;
DE   AltName: Full=Protein kinase K35;
GN   Name=CDK8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=7568034; DOI=10.1073/pnas.92.19.8871;
RA   Tassan J.-P., Jaquenoud M., Leopold P., Schultz S.J., Nigg E.A.;
RT   "Identification of human cyclin-dependent kinase 8, a putative protein
RT   kinase partner for cyclin C.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8871-8875(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   MEDIATOR COMPLEX.
RX   PubMed=9734358; DOI=10.1016/S1097-2765(00)80131-8;
RA   Sun X., Zhang Y., Cho H., Rickert P., Lees E., Lane W.S., Reinberg D.;
RT   "NAT, a human complex containing Srb polypeptides that functions as a
RT   negative regulator of activated transcription.";
RL   Mol. Cell 2:213-222(1998).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SMCC
RP   COMPLEX.
RX   PubMed=10024883; DOI=10.1016/S1097-2765(00)80178-1;
RA   Gu W., Malik S., Ito M., Yuan C.-X., Fondell J.D., Zhang X.,
RA   Martinez E., Qin J., Roeder R.G.;
RT   "A novel human SRB/MED-containing cofactor complex, SMCC, involved in
RT   transcription regulation.";
RL   Mol. Cell 3:97-108(1999).
RN   [7]
RP   ERRATUM.
RA   Gu W., Malik S., Ito M., Yuan C.-X., Fondell J.D., Zhang X.,
RA   Martinez E., Qin J., Roeder R.G.;
RL   Mol. Cell 3:541-541(1999).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-173.
RX   PubMed=10993082; DOI=10.1038/35024111;
RA   Akoulitchev S., Chuikov S., Reinberg D.;
RT   "TFIIH is negatively regulated by cdk8-containing mediator
RT   complexes.";
RL   Nature 407:102-106(2000).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH MAML1.
RX   PubMed=15546612; DOI=10.1016/j.molcel.2004.10.014;
RA   Fryer C.J., White J.B., Jones K.A.;
RT   "Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and
RT   coordinate activation with turnover.";
RL   Mol. Cell 16:509-520(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   MEDIATOR COMPLEX.
RX   PubMed=15175163; DOI=10.1016/j.molcel.2004.05.006;
RA   Sato S., Tomomori-Sato C., Parmely T.J., Florens L., Zybailov B.,
RA   Swanson S.K., Banks C.A.S., Jin J., Cai Y., Washburn M.P.,
RA   Conaway J.W., Conaway R.C.;
RT   "A set of consensus mammalian mediator subunits identified by
RT   multidimensional protein identification technology.";
RL   Mol. Cell 14:685-691(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE MEDIATOR
RP   COMPLEX, AND ASSOCIATION OF THE MEDIATOR COMPLEX WITH RNA POLYMERASE
RP   II.
RX   PubMed=15989967; DOI=10.1016/j.molcel.2005.05.015;
RA   Zhang X., Krutchinsky A., Fukuda A., Chen W., Yamamura S., Chait B.T.,
RA   Roeder R.G.;
RT   "MED1/TRAP220 exists predominantly in a TRAP/Mediator subpopulation
RT   enriched in RNA polymerase II and is required for ER-mediated
RT   transcription.";
RL   Mol. Cell 19:89-100(2005).
RN   [12]
RP   INTERACTION WITH CTNNB1; GLI3; MED1; MED6; MED12 AND MED23.
RX   PubMed=17000779; DOI=10.1128/MCB.00443-06;
RA   Zhou H., Kim S., Ishii S., Boyer T.G.;
RT   "Mediator modulates Gli3-dependent Sonic hedgehog signaling.";
RL   Mol. Cell. Biol. 26:8667-8682(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-403 IN COMPLEX WITH CCNC
RP   AND INHIBITOR.
RX   PubMed=21806996; DOI=10.1016/j.jmb.2011.07.020;
RA   Schneider E.V., Bottcher J., Blaesse M., Neumann L., Huber R.,
RA   Maskos K.;
RT   "The structure of CDK8/CycC implicates specificity in the CDK/cyclin
RT   family and reveals interaction with a deep pocket binder.";
RL   J. Mol. Biol. 412:251-266(2011).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-189 AND CYS-424.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of the Mediator complex, a coactivator
CC       involved in regulated gene transcription of nearly all RNA
CC       polymerase II-dependent genes. Mediator functions as a bridge to
CC       convey information from gene-specific regulatory proteins to the
CC       basal RNA polymerase II transcription machinery. Mediator is
CC       recruited to promoters by direct interactions with regulatory
CC       proteins and serves as a scaffold for the assembly of a functional
CC       preinitiation complex with RNA polymerase II and the general
CC       transcription factors. Phosphorylates the CTD (C-terminal domain)
CC       of the large subunit of RNA polymerase II (RNAp II), which may
CC       inhibit the formation of a transcription initiation complex.
CC       Phosphorylates CCNH leading to down-regulation of the TFIIH
CC       complex and transcriptional repression. Recruited through
CC       interaction with MAML1 to hyperphosphorylate the intracellular
CC       domain of NOTCH, leading to its degradation.
CC       {ECO:0000269|PubMed:10993082, ECO:0000269|PubMed:15546612}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:10993082}.
CC   -!- CATALYTIC ACTIVITY: ATP + [DNA-directed RNA polymerase] = ADP +
CC       [DNA-directed RNA polymerase] phosphate.
CC       {ECO:0000269|PubMed:10993082}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Component of the Mediator complex, which is composed of
CC       MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13,
CC       MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21,
CC       MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31,
CC       CCNC, CDK8 and CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8
CC       subunits form a distinct module termed the CDK8 module. Mediator
CC       containing the CDK8 module is less active than Mediator lacking
CC       this module in supporting transcriptional activation. Individual
CC       preparations of the Mediator complex lacking one or more distinct
CC       subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and
CC       TRAP. The cylin/CDK pair formed by CCNC/CDK8 also associates with
CC       the large subunit of RNA polymerase II. Interacts with CTNNB1,
CC       GLI3 and MAML1. {ECO:0000269|PubMed:10024883,
CC       ECO:0000269|PubMed:15175163, ECO:0000269|PubMed:15546612,
CC       ECO:0000269|PubMed:15989967, ECO:0000269|PubMed:17000779,
CC       ECO:0000269|PubMed:21806996, ECO:0000269|PubMed:9734358}.
CC   -!- INTERACTION:
CC       P24863:CCNC; NbExp=24; IntAct=EBI-394377, EBI-395261;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49336-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49336-2; Sequence=VSP_029970;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X85753; CAA59754.1; -; mRNA.
DR   EMBL; AL590108; CAH72300.1; -; Genomic_DNA.
DR   EMBL; AL159159; CAH72300.1; JOINED; Genomic_DNA.
DR   EMBL; AL159159; CAI16960.1; -; Genomic_DNA.
DR   EMBL; AL590108; CAI16960.1; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08386.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08387.1; -; Genomic_DNA.
DR   EMBL; BC069634; AAH69634.1; -; mRNA.
DR   EMBL; BC104492; AAI04493.1; -; mRNA.
DR   EMBL; BC105950; AAI05951.1; -; mRNA.
DR   EMBL; BC107601; AAI07602.1; -; mRNA.
DR   CCDS; CCDS9317.1; -. [P49336-1]
DR   PIR; I37227; I37227.
DR   RefSeq; NP_001251.1; NM_001260.2. [P49336-1]
DR   RefSeq; NP_001305297.1; NM_001318368.1. [P49336-2]
DR   UniGene; Hs.382306; -.
DR   UniGene; Hs.695166; -.
DR   PDB; 3RGF; X-ray; 2.20 A; A=1-403.
DR   PDB; 4CRL; X-ray; 2.40 A; A=1-403.
DR   PDB; 4F6S; X-ray; 2.60 A; A=1-403.
DR   PDB; 4F6U; X-ray; 2.10 A; A=1-403.
DR   PDB; 4F6W; X-ray; 2.39 A; A=1-403.
DR   PDB; 4F70; X-ray; 3.00 A; A=1-403.
DR   PDB; 4F7J; X-ray; 2.60 A; A=1-403.
DR   PDB; 4F7L; X-ray; 2.90 A; A=1-403.
DR   PDB; 4F7N; X-ray; 2.65 A; A=1-403.
DR   PDB; 4F7S; X-ray; 2.20 A; A=1-403.
DR   PDB; 4G6L; X-ray; 2.70 A; A=1-403.
DR   PDB; 5BNJ; X-ray; 2.64 A; A=1-403.
DR   PDB; 5CEI; X-ray; 2.24 A; A=1-403.
DR   PDB; 5FGK; X-ray; 2.36 A; A=1-362.
DR   PDB; 5HBE; X-ray; 2.38 A; A=1-362.
DR   PDB; 5HBH; X-ray; 2.50 A; A=1-362.
DR   PDB; 5HBJ; X-ray; 3.00 A; A=1-362.
DR   PDB; 5HNB; X-ray; 2.35 A; A=1-362.
DR   PDB; 5HVY; X-ray; 2.39 A; A=1-403.
DR   PDB; 5I5Z; X-ray; 2.60 A; A=1-362.
DR   PDB; 5ICP; X-ray; 2.18 A; A=1-362.
DR   PDB; 5IDN; X-ray; 2.26 A; A=1-364.
DR   PDB; 5IDP; X-ray; 2.65 A; A=1-364.
DR   PDBsum; 3RGF; -.
DR   PDBsum; 4CRL; -.
DR   PDBsum; 4F6S; -.
DR   PDBsum; 4F6U; -.
DR   PDBsum; 4F6W; -.
DR   PDBsum; 4F70; -.
DR   PDBsum; 4F7J; -.
DR   PDBsum; 4F7L; -.
DR   PDBsum; 4F7N; -.
DR   PDBsum; 4F7S; -.
DR   PDBsum; 4G6L; -.
DR   PDBsum; 5BNJ; -.
DR   PDBsum; 5CEI; -.
DR   PDBsum; 5FGK; -.
DR   PDBsum; 5HBE; -.
DR   PDBsum; 5HBH; -.
DR   PDBsum; 5HBJ; -.
DR   PDBsum; 5HNB; -.
DR   PDBsum; 5HVY; -.
DR   PDBsum; 5I5Z; -.
DR   PDBsum; 5ICP; -.
DR   PDBsum; 5IDN; -.
DR   PDBsum; 5IDP; -.
DR   ProteinModelPortal; P49336; -.
DR   SMR; P49336; -.
DR   BioGrid; 107458; 107.
DR   DIP; DIP-32595N; -.
DR   IntAct; P49336; 78.
DR   MINT; MINT-3017285; -.
DR   STRING; 9606.ENSP00000370938; -.
DR   BindingDB; P49336; -.
DR   ChEMBL; CHEMBL5719; -.
DR   DrugBank; DB03496; Flavopiridol.
DR   GuidetoPHARMACOLOGY; 1980; -.
DR   iPTMnet; P49336; -.
DR   PhosphoSitePlus; P49336; -.
DR   BioMuta; CDK8; -.
DR   DMDM; 1345718; -.
DR   EPD; P49336; -.
DR   MaxQB; P49336; -.
DR   PaxDb; P49336; -.
DR   PeptideAtlas; P49336; -.
DR   PRIDE; P49336; -.
DR   DNASU; 1024; -.
DR   Ensembl; ENST00000381527; ENSP00000370938; ENSG00000132964. [P49336-1]
DR   GeneID; 1024; -.
DR   KEGG; hsa:1024; -.
DR   UCSC; uc001uqr.2; human. [P49336-1]
DR   CTD; 1024; -.
DR   DisGeNET; 1024; -.
DR   GeneCards; CDK8; -.
DR   HGNC; HGNC:1779; CDK8.
DR   HPA; HPA044721; -.
DR   MIM; 603184; gene.
DR   neXtProt; NX_P49336; -.
DR   OpenTargets; ENSG00000132964; -.
DR   PharmGKB; PA26315; -.
DR   eggNOG; KOG0666; Eukaryota.
DR   eggNOG; ENOG410XPPA; LUCA.
DR   GeneTree; ENSGT00530000064012; -.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P49336; -.
DR   KO; K02208; -.
DR   OMA; KHVNVIT; -.
DR   OrthoDB; EOG091G0812; -.
DR   PhylomeDB; P49336; -.
DR   TreeFam; TF101025; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SignaLink; P49336; -.
DR   SIGNOR; P49336; -.
DR   ChiTaRS; CDK8; human.
DR   GeneWiki; Cyclin-dependent_kinase_8; -.
DR   GenomeRNAi; 1024; -.
DR   PRO; PR:P49336; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000132964; -.
DR   CleanEx; HS_CDK8; -.
DR   ExpressionAtlas; P49336; baseline and differential.
DR   Genevisible; P49336; HS.
DR   GO; GO:0016592; C:mediator complex; IDA:MGI.
DR   GO; GO:0005730; C:nucleolus; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome.
DR   GO; GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; ATP-binding;
KW   Complete proteome; Kinase; Nucleotide-binding; Nucleus; Polymorphism;
KW   Reference proteome; Repressor; Serine/threonine-protein kinase;
KW   Transcription; Transcription regulation; Transferase.
FT   CHAIN         1    464       Cyclin-dependent kinase 8.
FT                                /FTId=PRO_0000085797.
FT   DOMAIN       21    335       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      27     35       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION        1     15       Interaction with CCNC.
FT   COMPBIAS    373    377       Poly-Gln.
FT   ACT_SITE    151    151       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      52     52       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VAR_SEQ     370    370       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029970.
FT   VARIANT     189    189       D -> N (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041980.
FT   VARIANT     424    424       R -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041981.
FT   MUTAGEN     173    173       D->A: Abrogates kinase activity and
FT                                TFIIH-dependent transcriptional
FT                                repression.
FT                                {ECO:0000269|PubMed:10993082}.
FT   HELIX         3     12       {ECO:0000244|PDB:4F6U}.
FT   HELIX        16     19       {ECO:0000244|PDB:4F6U}.
FT   STRAND       26     42       {ECO:0000244|PDB:4F6U}.
FT   STRAND       49     58       {ECO:0000244|PDB:4F6U}.
FT   HELIX        61     72       {ECO:0000244|PDB:4F6U}.
FT   STRAND       83     87       {ECO:0000244|PDB:4F6U}.
FT   TURN         88     91       {ECO:0000244|PDB:4F6U}.
FT   STRAND       92     98       {ECO:0000244|PDB:4F6U}.
FT   STRAND      101    103       {ECO:0000244|PDB:3RGF}.
FT   HELIX       104    113       {ECO:0000244|PDB:4F6U}.
FT   HELIX       125    144       {ECO:0000244|PDB:4F6U}.
FT   HELIX       154    156       {ECO:0000244|PDB:4F6U}.
FT   STRAND      157    159       {ECO:0000244|PDB:4F6U}.
FT   TURN        164    167       {ECO:0000244|PDB:4F6U}.
FT   STRAND      169    171       {ECO:0000244|PDB:4F6U}.
FT   HELIX       179    181       {ECO:0000244|PDB:5ICP}.
FT   HELIX       202    205       {ECO:0000244|PDB:4F6U}.
FT   HELIX       213    229       {ECO:0000244|PDB:4F6U}.
FT   HELIX       249    259       {ECO:0000244|PDB:4F6U}.
FT   HELIX       264    266       {ECO:0000244|PDB:4F6U}.
FT   HELIX       268    272       {ECO:0000244|PDB:4F6U}.
FT   HELIX       276    282       {ECO:0000244|PDB:4F6U}.
FT   HELIX       285    288       {ECO:0000244|PDB:4F6U}.
FT   HELIX       293    299       {ECO:0000244|PDB:4F6U}.
FT   HELIX       307    315       {ECO:0000244|PDB:4F6U}.
FT   HELIX       320    322       {ECO:0000244|PDB:4F6U}.
FT   HELIX       326    330       {ECO:0000244|PDB:4F6U}.
FT   HELIX       333    335       {ECO:0000244|PDB:4F6U}.
FT   STRAND      337    339       {ECO:0000244|PDB:4F6U}.
FT   TURN        345    348       {ECO:0000244|PDB:4F6U}.
SQ   SEQUENCE   464 AA;  53284 MW;  00CBAB6CE354605F CRC64;
     MDYDFKVKLS SERERVEDLF EYEGCKVGRG TYGHVYKAKR KDGKDDKDYA LKQIEGTGIS
     MSACREIALL RELKHPNVIS LQKVFLSHAD RKVWLLFDYA EHDLWHIIKF HRASKANKKP
     VQLPRGMVKS LLYQILDGIH YLHANWVLHR DLKPANILVM GEGPERGRVK IADMGFARLF
     NSPLKPLADL DPVVVTFWYR APELLLGARH YTKAIDIWAI GCIFAELLTS EPIFHCRQED
     IKTSNPYHHD QLDRIFNVMG FPADKDWEDI KKMPEHSTLM KDFRRNTYTN CSLIKYMEKH
     KVKPDSKAFH LLQKLLTMDP IKRITSEQAM QDPYFLEDPL PTSDVFAGCQ IPYPKREFLT
     EEEPDDKGDK KNQQQQQGNN HTNGTGHPGN QDSSHTQGPP LKKVRVVPPT TTSGGLIMTS
     DYQRSNPHAA YPNPGPSTSQ PQSSMGYSAT SQQPPQYSHQ THRY
//
